View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
April 28, 2020

Accurate Diagnostic to launch antibody test for Covid-19 diagnostics

Accurate Diagnostic Laboratories is set to launch its immunoglobulin class IgG and IgM antibody testing this week to help the US meet the demand for wider Covid-19 diagnostics.


Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates

Free Report
img

Build resilience in the face of COVID-19 disruption

COVID-19 has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities. Are you interested in actionable insights on the business challenges induced by the pandemic? GlobalData's cross-sector report analyzes the significance of this major disruptive theme across industry verticals. It provides side-by-side research of alternative datasets to present you with unique quantitative analysis of the effects of COVID-19 and how these differ across sectors. Additionally, it offers qualitative analysis of each sector and analyzes COVID-19’s impact on leading companies. Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today.
by GlobalData
Enter your details here to receive your free Report.

Follow the latest updates of the outbreak on our timeline.


Accurate Diagnostic Laboratories is set to launch its immunoglobulin class IgG and IgM antibody testing this week to help the US meet the demand for wider Covid-19 diagnostics.

The lab will initially use the Diazyme testing platform to offer the antibody test.

Earlier this month, Accurate Diagnostic and RUCDR Infinite Biologics developed new collection approach that uses saliva as the primary test biomaterial for Covid-19.

The method enables self-administered sample collection by individuals who are in quarantine or self-isolation.

With the launch of the new serology Covid-19 diagnostics test, the lab expects to meet both sides of the laboratory testing equation by diagnosing patients with active infection and those who have been infected before.

To continue scaling up its capacity to meet the testing demand in the local and national markets, Accurate Diagnostic is working with its vendor partners.

Accurate Diagnostic Laboratories CEO and owner Rupen Patel said: “While there is still a lot of scientific ambiguity on whether the detection of antibodies confirms that people exposed to Covid-19 have developed an immune response, most believe that antibody testing is a significant part of our fight against the virus.

“There is no playbook for handling this pandemic but I am extremely proud of the Accurate Diagnostic Labs family and all our colleagues in the industry for working tirelessly to do our part by expanding testing.”

Recently, Diazyme has launched Diazyme DZ-Lite SARS-CoV-2 IgG and SARS-CoV-2 IgM CLIA test kits for detecting Covid-19.

They are run on the fully automated Diazyme DZ-Lite 3000 Plus chemiluminescence analyser that Accurate Diagnostics will also use for its immunoglobulin class IgG and IgM antibody testing.

Related Companies

Free Report
img

Build resilience in the face of COVID-19 disruption

COVID-19 has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities. Are you interested in actionable insights on the business challenges induced by the pandemic? GlobalData's cross-sector report analyzes the significance of this major disruptive theme across industry verticals. It provides side-by-side research of alternative datasets to present you with unique quantitative analysis of the effects of COVID-19 and how these differ across sectors. Additionally, it offers qualitative analysis of each sector and analyzes COVID-19’s impact on leading companies. Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network